Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,757 | -1,663 | -5,270 | -1,583 | -770 |
| Depreciation Amortization | 34 | 9 | 40 | 32 | 20 |
| Accounts receivable | N/A | -225 | N/A | -6 | -9 |
| Accounts payable and accrued liabilities | 114 | 178 | N/A | 371 | 287 |
| Other Working Capital | 9,025 | 141 | -60 | -253 | -324 |
| Other Operating Activity | 1,964 | 213 | 3,120 | -15 | -68 |
| Operating Cash Flow | $4,380 | $-1,347 | $-2,170 | $-1,454 | $-864 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -474 | -47 | -90 | -82 | -81 |
| Investing Cash Flow | $-474 | $-47 | $-90 | $-82 | $-81 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000 | N/A | 1,500 | 800 |
| Common Stock Issued | 2,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 45,957 | 0 | 2,480 | 0 | 0 |
| Financing Cash Flow | $47,957 | $1,000 | $2,480 | $1,500 | $800 |
| Exchange Rate Effect | 1 | -1 | -7 | -23 | -21 |
| Beginning Cash Position | 564 | 564 | 350 | 357 | 357 |
| End Cash Position | 52,428 | 169 | 560 | 298 | 191 |
| Net Cash Flow | $51,864 | $-395 | $200 | $-59 | $-166 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,380 | -1,347 | -2,170 | -1,454 | -864 |
| Capital Expenditure | -474 | -47 | N/A | -82 | -81 |
| Free Cash Flow | 3,906 | -1,394 | -2,170 | -1,536 | -945 |